Syndax Pharmaceuticals
SNDX
$21.33
Share price
1.28%
Change (1 day)
3.80%
Change (1 year)
Categories
Syndax Pharmaceuticals (SNDX) - Cash on Hand
Cash on Hand as of December 2023 : $0.57 B
According to Syndax Pharmaceuticals's latest financial reports the company has $0.57 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Syndax Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.57 B | 19.24% |
| 2022-12-31 | $0.48 B | 8.41% |
| 2021-12-31 | $0.44 B | 52.47% |
| 2020-12-31 | $0.29 B | 390.28% |
| 2019-12-31 | $59.77 M | -26.12% |
| 2018-12-31 | $80.91 M | -37.75% |
| 2017-12-31 | $0.12 B | 23.4% |
| 2016-12-31 | $0.10 B | 21.78% |
| 2015-12-31 | $86.48 M | 608.46% |
| 2014-12-31 | $12.2 M | -14.41% |
| 2013-12-31 | $14.26 M | 2171.34% |
| 2012-12-31 | $0.62 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -63.96% | 🇺🇸 USA |